SHE/300142 (SHE/300142)

Shenzhen Stock Exchange: SHE/300142 · CNY

CN¥12.2

+0.11 (+0.9%)· Recorded snapshot

Market cap	19.5B
Revenue (ttm)	2.1B
Net income (ttm)	188.8M
EPS (ttm)	CN¥0.12
Shares out	1.6B
P/E (trailing)	103.7x
Dividend	CN¥0.16 (1.27%)
Volume	39,872,808
Beta	0.57

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.1B
Net income (ttm): 188.8M
EPS (ttm): CN¥0.12
P/E (trailing): 103.7x
Market cap: 19.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E103.7

P25 n/aP50 n/aP75 n/a

ROE2

P25 n/aP50 n/aP75 n/a

ROIC1.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SHE/300142 indicators

Market & fundamental data

Available fields

245

Groups with data

Currency

CNY

Showing 245 of 245 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CNY
Country	China
Country code	CN
Earnings date	2026-10-30
Employees	1,981
Employees change	-407
Employees growth	-17.04%
Enterprise value	CNY 19.9B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2001
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CNE100000WN2
Last earnings date	2026-08-29
Last refreshed	2026-10-28
Last stock split date	2015-10-14
Last stock split type	Forward
Market cap	CNY 19.5B
Next earnings date	2026-10-30
Price	CNY 12.17
Price currency	CNY
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	she/300142
Website	https://www.walvax.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	184.33x
Average P/E ratio (3Y)	223.35x
Average P/E ratio (5Y)	182.65x
Earnings yield	0.96%
EV/Earnings	105.54x
EV/EBIT	105.51x
EV/EBITDA	36.1x
EV/FCF	1,081.12x
EV/Sales	9.5x
FCF / EV yield	0.09%
FCF yield	0.09%
Graham number	3.3948
Graham upside	-72.11%
Industry forward P/E	17.34x
Industry P/E	33.74x
Lynch fair value	CNY 0.59
Lynch upside	-95.18%
P/B ratio	2.66x
P/E ratio	103.71x
P/FCF ratio	1,056.18x
P/OCF ratio	35.51x
P/S ratio	9.28x
Price / tangible book value	3.18x
Price/EBITDA ratio	35.86x
Sector forward P/E	20.65x
Sector P/E	37.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9%
EBITDA margin	25.87%
Effective tax rate	20.19%
FCF margin	0.88%
Gross margin	75.76%
Operating margin	9%
Pretax margin	10.64%
Profit margin	9%
Profit per employee	CNY 95,292
Profitable years	8
Revenue per employee	CNY 1.1M
ROA	0.96%
ROA (5Y)	2.65%
ROCE	2.21%
ROE	1.97%
ROE (5Y)	4.59%
ROIC	1.93%
ROIC (5Y)	7.04%
Tax / revenue	2.15%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	1,163.86%
EPS growth 3Y	-37.3%
EPS growth 5Y	-31.91%
EPS growth years	1
FCF growth	-97.27%
FCF growth (Q)	-38.57%
FCF growth 3Y	-51.14%
Gross profit growth	-9.61%
Gross profit growth (Q)	-39.65%
Gross profit growth 3Y	-28.01%
Gross profit growth 5Y	-13.36%
Net income growth	1,178.9%
Net income growth 3Y	-37.22%
Net income growth 5Y	-31.6%
Net income growth years	1
OCF growth	-48.41%
OCF growth (Q)	-30.24%
OCF growth 3Y	-22.66%
OCF growth 5Y	31.63%
Operating income growth 3Y	-45.6%
Operating income growth 5Y	-32.08%
Revenue growth	-17.47%
Revenue growth (Q)	-43.59%
Revenue growth (QoQ)	-12.05%
Revenue growth 10Y	9.01%
Revenue growth 3Y	-24.66%
Revenue growth 5Y	-10.8%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CNY -529.8M
Depreciation and amortization	CNY 353.9M
EBIT	CNY 188.8M
EBITDA	CNY 542.8M
EPS	CNY 0.12
FCF per share	CNY 0.01
Financing cash flow	CNY -2.1B
Free cash flow	CNY 18.4M
Gross profit	CNY 1.6B
Income taxes	CNY 45.1M
Investing cash flow	CNY -220.2M
Net borrowing	CNY 838.8M
Net cash flow	CNY -1.8B
Net income	CNY 188.8M
Operating income	CNY 188.8M
Revenue	CNY 2.1B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.68
Book value per share	CNY 4.36
Debt / EBITDA	2.35
Debt / equity	0.18
Debt / FCF	70.47
Goodwill	CNY 33.7M
Interest coverage	11.02
Long-term assets	CNY 6.5B
Long-term liabilities	CNY 1.2B
Net cash (debt)	CNY -109.4M
Net cash / market cap	-0.56%
Net debt / EBITDA	0.2
Net debt / equity	0.01
Net debt / FCF	5.94
Piotroski F-Score	5
Property, plant and equipment	CNY 4B
Shareholders' equity	CNY 7.3B
Tangible book value	CNY 6.1B
Tangible book value per share	CNY 3.82
Total assets	CNY 10.5B
Total cash	CNY 1.2B
Total debt	CNY 1.3B
Total liabilities	CNY 3.2B
WACC	6.99%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.17
Current assets	CNY 4B
Current liabilities	CNY 2B
Current ratio	2.07
Inventory turnover	0.83
Net working capital	CNY 1.4B
Quick ratio	1.7
Working capital	CNY 2.1B
Working capital turnover	0.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.2%
Dividend growth	1,450%
Dividend growth (10Y)	24.98%
Dividend growth (3Y)	149.33%
Dividend growth (5Y)	17.23%
Dividend growth years	0
Dividend payment date	2026-06-24
Dividend payment years	8
Dividend payout frequency	Semi-Annual
Dividend per share	CNY 0.16
Dividend yield	1.27%
Ex-dividend date	2026-06-24
FCF payout ratio	1,345.14%
Last dividend	CNY 0.13
Payout ratio	545.28%
Shareholder yield	0.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	19.55%
10Y return CAGR	1.98%
10Y total return	21.66%
150-day SMA	CNY 13.02
15Y price change	109.97%
15Y return CAGR	5.3%
15Y total return	117.04%
1D price change	0.91%
1M price change	-10.38%
1M total return	-10.38%
1W price change	-5.8%
1W total return	-5.8%
1Y price change	7.32%
1Y return CAGR	8.69%
1Y total return	8.69%
20-day SMA	CNY 13.32
200-day SMA	CNY 12.79
3M price change	-1.54%
3M total return	-1.54%
3Y price change	-46.22%
3Y return CAGR	-18.28%
3Y total return	-45.44%
50-day SMA	CNY 13.54
50-day SMA vs 200-day SMA	50over200
52-week high	CNY 16.97
52-week high date	2026-08-21
52-week low	CNY 10.88
52-week low date	2025-12-31
5Y price change	-78.71%
5Y return CAGR	-26.39%
5Y total return	-78.39%
6M price change	1.84%
6M total return	2.87%
All-time high	CNY 96.73
All-time high date	2021-08-05
All-time low	CNY 3.80
All-time low date	2012-01-18
Average true range (ATR)	CNY 0.60
Average volume	79.6M
Beta (1Y)	0.6
Beta (2Y)	0.58
Beta (5Y)	0.57
Change from 52-week high	-28.29%
Change from 52-week low	11.86%
Change from all-time high	-87.42%
Change from all-time low	220.43%
Change from open	-0.65%
Day's gap	1.58%
Dollar volume	CNY 485.3M
High price	CNY 12.34
Low price	CNY 11.91
Monthly RSI	42.1
Open price	CNY 12.25
Position in 52-week range	60.47%
Previous close	CNY 12.06
Price vs 150-day SMA	-6.51%
Price vs 20-day SMA	-8.64%
Price vs 200-day SMA	-4.82%
Price vs 50-day SMA	-10.1%
Relative volume	0.47
RSI	37.29
Sharpe ratio	0.29
Sharpe ratio (3Y)	-0.33
Sharpe ratio (5Y)	-0.7
Sortino ratio	0.61
Sortino ratio (3Y)	-0.39
Sortino ratio (5Y)	-0.94
Volume	39.9M
Weekly RSI	45.97
YTD price change	11.55%
YTD total return	12.97%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.5B
Shares change (QoQ)	-0.1%
Shares change (YoY)	1.2%
Shares held by insiders	6.28%
Shares held by institutions	13.54%
Shares outstanding	1.6B

Deeper analysis on SHE/300142

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SHE/300142 report

Is a complete SHE/300142 research report available?

No complete published report is available for she/300142 (SHE/300142) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SHE/300142 (SHE/300142)

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/300142

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/300142 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SHE/300142

Frequently asked questions